Patents by Inventor Rosalinda SORRENTINO

Rosalinda SORRENTINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS FOR THE DIAGNOSIS OF LUNG CANCER
    Publication number: 20230341403
    Abstract: The present invention relates to a method for the diagnosis and/or to monitor the development and/or to provide a prognosis on the development of lung cancer in an individual, including the detection of the expression levels of the isoform 4 of the human caspase-4 protein in biological samples. The present invention further relates to a kit and reagents for the detection of the expression levels of said isoform 4, as well as a compound inhibitor of said isoform 4 for use in the treatment and/or prevention of lung cancer.
    Type: Application
    Filed: July 14, 2021
    Publication date: October 26, 2023
    Inventors: Aldo PINTO, Rosalinda SORRENTINO
  • Method of treating cancer using a caspase-4 inhibitor
    Patent number: 10976318
    Abstract: The present invention relates to the use as a biomarker of the active form of a human caspase protein, preferably the human caspase-4 or caspase-1, or of the active form of the protein encoded by an orthologue gene of the human caspase protein, preferably by an orthologue gene of the human caspase-4, for example the murine caspase-11 protein, in a method of diagnosis and/or prognosis and/or of monitoring the progression of a tumor, particularly lung cancer.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: April 13, 2021
    Assignee: IMMUNEPHARMA S.R.L.
    Inventors: Aldo Pinto, Rita Patrizia Aquino, Rosalinda Sorrentino, Michela Terlizzi
  • LUNG CANCER'S BIOMARKERS AND THEIR METHODS AND DIAGNOSTIC KIT
    Publication number: 20170067898
    Abstract: The present invention relates to the use as a biomarker of the active form of a human caspase protein, preferably the human caspase-4 or caspase-1, or of the active form of the protein encoded by an orthologue gene of the human caspase protein, preferably by an orthologue gene of the human caspase-4, for example the murine caspase-11 protein, in a method of diagnosis and/or prognosis and/or of monitoring the progression of a tumor, particularly lung cancer.
    Type: Application
    Filed: February 19, 2015
    Publication date: March 9, 2017
    Inventors: Aldo PINTO, Rita Patrizia AQUINO, Rosalinda SORRENTINO, Michela TERLIZZI